Apple Medical Research is categorized under Commercial Medical Research in Miami, FL and active since 2004.
Apple Medical Research was established in 2004, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Jose Manzano, President at the company’s single location by writing to 6850 Coral Way # 409, Miami, Florida FL 33155 or by phoning (305) 667-8434. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Apple Medical Research |
| Contact Person: | Jose Manzano, President |
| Address: | 6850 Coral Way # 409, Miami, Florida 33155 |
| Phone Number: | (305) 667-8434 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 6214930 |
| Share This Business: |
Apple Medical Research was started in 2004 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Jose Manzano, President for inquiries that concern Apple Medical Research by calling the company number (305) 667-8434, as your correspondence is most welcome. Additionally, the physical location of the single location of Apple Medical Research can be found at the coordinates 25.747969,-80.305488 as well as the street address 6850 Coral Way # 409 in Miami, Florida 33155.
For its online presence, you may visit Apple Medical Research’s website at and engage with its social media outlets through on Twitter and on Facebook.